TAS2R1: A Transmembrane Protein Involved in Various Physiological Processes

Target Name: TAS2R1

NCBI ID: G50834

TAS2R1

TAS2R1: A Transmembrane Protein Involved in Various Physiological Processes

TAS2R1 (Taste 2 Receptor Member 1) is a transmembrane protein that is expressed in various tissues, including the tongue, gut, and brain. It is a member of the TAS2R family of G protein-coupled receptors, which are involved in taste perception and other physiological processes.

TAS2R1 is a 21-kDa protein that consists of an extracellular region, a transmembrane region, and an intracellular region. The extracellular region has seven transmembrane domains, including a N-terminus, a T-terminus, a P-terminus, a G伪- converting enzyme (GE), a G尾-converting enzyme (GBE), a S-layer, and a D-layer. The transmembrane region has a variable number of transmembrane domains, ranging from four to eight, and includes a putative intracellular domain ( ICD).

TAS2R1 is involved in taste perception and has been shown to play a role in the taste sensitivity of individuals with advice syndrome (GES) and in the efficacy of taste drugs. It is also a potential drug target for several diseases, including cancer, neurodegenerative diseases, and psychiatric disorders.

TAS2R1 has been shown to interact with several other proteins, including GABA, which is a neurotransmitter that has effects on mood, anxiety, and other physiological processes. GABA signaling is involved in the regulation of many cellular processes, including cell survival, growth, and differentiation. TAS2R1 has been shown to interact with GABA receptors and to modulate GABA signaling in various tissues.

TAS2R1 has also been shown to interact with several other proteins that are involved in the development and progression of cancer. For example, TAS2R1 has been shown to interact with the oncogene PIK3CA, which is involved in the development of many types of cancer. has also been shown to interact with the tumor suppressor protein p53, which is involved in the regulation of cell growth and apoptosis.

TAS2R1 has been shown to be involved in the regulation of neurotransmitter signaling in the brain. For example, TAS2R1 has been shown to interact with the neurotransmitter dopamine, which is involved in the regulation of mood, motivation, and other physiological processes. TAS2R1 has also has been shown to interact with the neurotransmitter GABA, which is involved in the regulation of many cellular processes, including sleep, anxiety, and other physiological processes.

TAS2R1 has been shown to be involved in the regulation of inflammation in various tissues. For example, TAS2R1 has been shown to interact with the cytokine interleukin-1 (IL-1), which is involved in the regulation of inflammation and immune responses.

In conclusion, TAS2R1 is a transmembrane protein that is involved in various physiological processes, including taste perception, cancer, neurodegenerative diseases, and psychiatric disorders. Further It is a potential drug target for several diseases, including cancer, neurodegenerative diseases, and psychiatric disorders. research is needed to fully understand the role of TAS2R1 in these processes and to develop effective treatments for these diseases.

Protein Name: Taste 2 Receptor Member 1

Functions: Receptor that may play a role in the perception of bitterness and is gustducin-linked. May play a role in sensing the chemical composition of the gastrointestinal content. The activity of this receptor may stimulate alpha gustducin, mediate PLC-beta-2 activation and lead to the gating of TRPM5

The "TAS2R1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TAS2R1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets